Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $569.38 million. The enterprise value is $1.03 billion.
Important Dates
The last earnings date was Monday, November 10, 2025, before market open.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 162.68 million shares outstanding. The number of shares has increased by 9.90% in one year.
| Current Share Class | 162.68M |
| Shares Outstanding | 162.68M |
| Shares Change (YoY) | +9.90% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 2.38% |
| Owned by Institutions (%) | 67.55% |
| Float | 118.38M |
Valuation Ratios
The trailing PE ratio is 19.76 and the forward PE ratio is 8.14.
| PE Ratio | 19.76 |
| Forward PE | 8.14 |
| PS Ratio | 1.66 |
| Forward PS | 2.50 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.43 |
| P/OCF Ratio | 8.42 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.06, with an EV/FCF ratio of 15.20.
| EV / Earnings | 36.01 |
| EV / Sales | 3.03 |
| EV / EBITDA | 7.06 |
| EV / EBIT | 7.15 |
| EV / FCF | 15.20 |
Financial Position
The company has a current ratio of 1.13
| Current Ratio | 1.13 |
| Quick Ratio | 1.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.02 |
| Debt / FCF | 8.84 |
| Interest Coverage | 4.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 22.88% |
| Return on Invested Capital (ROIC) | 28.18% |
| Return on Capital Employed (ROCE) | 93.63% |
| Revenue Per Employee | $1.34M |
| Profits Per Employee | $112,842 |
| Employee Count | 253 |
| Asset Turnover | 0.86 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $65.02 million in taxes.
| Income Tax | 65.02M |
| Effective Tax Rate | 69.49% |
Stock Price Statistics
The stock price has decreased by -0.28% in the last 52 weeks. The beta is 0.18, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -0.28% |
| 50-Day Moving Average | 2.11 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 67.30 |
| Average Volume (20 Days) | 3,685,394 |
Short Selling Information
The latest short interest is 7.15 million, so 4.40% of the outstanding shares have been sold short.
| Short Interest | 7.15M |
| Short Previous Month | 4.76M |
| Short % of Shares Out | 4.40% |
| Short % of Float | 6.04% |
| Short Ratio (days to cover) | 2.64 |
Income Statement
In the last 12 months, IRWD had revenue of $338.99 million and earned $28.55 million in profits. Earnings per share was $0.18.
| Revenue | 338.99M |
| Gross Profit | 344.19M |
| Operating Income | 143.77M |
| Pretax Income | 93.57M |
| Net Income | 28.55M |
| EBITDA | 145.68M |
| EBIT | 143.77M |
| Earnings Per Share (EPS) | $0.18 |
Full Income Statement Balance Sheet
The company has $140.41 million in cash and $598.24 million in debt, giving a net cash position of -$457.83 million or -$2.81 per share.
| Cash & Cash Equivalents | 140.41M |
| Total Debt | 598.24M |
| Net Cash | -457.83M |
| Net Cash Per Share | -$2.81 |
| Equity (Book Value) | -264.16M |
| Book Value Per Share | -1.62 |
| Working Capital | 31.34M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $67.68 million and capital expenditures -$35,000, giving a free cash flow of $67.65 million.
| Operating Cash Flow | 67.68M |
| Capital Expenditures | -35,000 |
| Free Cash Flow | 67.65M |
| FCF Per Share | $0.42 |
Full Cash Flow Statement Margins
Gross margin is 101.54%, with operating and profit margins of 42.41% and 8.42%.
| Gross Margin | 101.54% |
| Operating Margin | 42.41% |
| Pretax Margin | 27.60% |
| Profit Margin | 8.42% |
| EBITDA Margin | 42.97% |
| EBIT Margin | 42.41% |
| FCF Margin | 19.96% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.90% |
| Shareholder Yield | -9.90% |
| Earnings Yield | 5.01% |
| FCF Yield | 11.86% |
Dividend Details Analyst Forecast
The average price target for IRWD is $5.34, which is 52.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.34 |
| Price Target Difference | 52.57% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -12.28% |
| EPS Growth Forecast (5Y) | 53.16% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -3.46 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.46 |
| Piotroski F-Score | 7 |